Clinical Trial Update: Treating Breast Cancer Patients Undergoing Trastuzumab Treatment With Carvedilol to Reduce Incidence of Heart Failure [Phase 2]

View source ↗

Summary

A Phase 2 trial is investigating whether adding carvedilol to trastuzumab in breast cancer patients can lower the risk of developing heart failure. The study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Heart Failure

Drugs mentioned

• Coreg (carvedilol)
• HERCEPTIN (trastuzumab)

Snippet

Sponsor: Mayo Clinic | Conditions: Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING